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Abstract  Article Info 
Introduction: One fifth of NPC patients have cranial nerve involvement at the time of diagnosis. The nearby 
location of rossenmuller fossa to lacerum foramen and middle base of the cranium provide way for tumor to 
extent directly to the cranium and adjacent cranial nerve. Facial palsy due to NPC does not happen very often, 
with incidence only compromise less than 1% of all cases. 
Case report: We reported a case of a 42 years old female with a complaint of blood stain rhinorea, mass in the 
nasopharynx, and facial assymmetry. Based on his history of illness, physical examination, imaging, and 
histopathology, the working diagnosis was Nasopharyngeal Carcinoma Stage IVA (T4 N0 M0) with facial nerve 
paresis (Hause-Brackmann V). The intervention done for the patient was radiotherapy.   
Conclusion: The patient refused to undergo chemotherapy, so the only therapy done in this case was 
radiotherapy. After undergoing 35 cycles of radiotherapy, a fair improvement was seen clinically on the patient.  
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1. CASE REPORT 
Nasopharyngeal carcinoma (NPC) is the most common cancer found among 
ENT malignancies in Indonesia with prevalence being on the highest 5th among 
all cancer (along with cervical cancer, breast cancer, lymph node cancer, and skin 
cancer). Not only being the most common found cancer on the head and neck, 
NPC also compromise almost 60% of tumor in head and neck, followed by 
cancer in the nose, paranasal sinus, throat, mouth, tonsil, and hypopharynx.  
Nasopharyngeal carcinoma (NPC) is a cancer originated from the mucosal lining 
of nasopharynx, with middle point most commonly located in fossa of 
Rosenmüller, where the tumor invades the adjacent space or organ. The incidence 
of NPC in Makassar, South Sulawesi, represented by NPC patient in Dadi 
Regional Hospital and Wahidin Sudirohusodo Central General Hospital in a 10-
year period (1990-1999), was reported by Kuhuwael in 2001 with a finding of 
274 cases (47.98% of all head and neck cancer) with man to woman ratio of 2.6:1. 
Whereas from January 2004 to June 2007, NPC was found to compromise only 
33% of all malignancy in ENT [1-3]. 
The etiology and risk factor of KNF is not yet known in exact, but there are 
hypothesis of some factors that is suspected to increase the risk of NPC. Epstein-
Barr Virus (EBV) infection might be the most studied etiologic factor of NPC. 
Using in-situ hybridization technique who targets EBV encoded RNA, the virus 
is able to be detected only inside the tumor cell, but not in a normal epithelial cell 
of the nasopharynx. In histopathological findings, EBV infection has a 
correlation with non-keratinized carcinoma both in differentiated and non-
differentiated subtypes, with differentiated types only correlates in high-risk 
areas. The role of individual genetic susceptibility towards the pathogenesis of 
NPC is indicated by the high incidence of NPC in certain ethnic. This is most 
noticeable on second and third generation of population coming from high-risk 
areas in which after emigration and assimilation with different culture, the risk 
seemed to remain higher than the local population [4, 5]. 
Large-scale epidemiological studies propose a correlation between dietary 
and social behavior with the increased risk of NPC. The most common factor 
mentioned is the history of salted fish (fish undergoing preservation process) 
consumption. The carcinogen which plays a role found in salted fish is volatile 
n-nitrosamines, which induces DNA damage and chronic inflammation in 
mucosal lining of nasopharynx. Consumption of other food associated with the 
incidence of NPC are pickled vegetables, fermented food, herbal tea, slow-
cooked soup, alcohol, animal products, carbohydrates, and unsaturated fatty 
acids. Other than dietary factors, the environmental factors that is suspected to 
play a role are oral hygiene, inhalation of wood dust, smoke, formaldehyde, and 
chemical material [6, 7]. 
 
Picture 1. The role of EBV in the pathogenesis of NPC [6]. 
 
The symptoms of NPC are categorized in 4 groups, including 
nasopharyngeal, ear, cranial nerve, and neck or its metastatic symptoms. The 
most common symptom is a lump on the neck, where this usually suggest a 
metastasis in neck lymph nodes. Hearing disturbance is one of the early 
symptoms due to the close position of tumor origin, fossa of Rosenmuller, 
to the eustachian tube. Disturbance in the ear compromised of tinnitus, 
sensation of fullness in the ear, or ear pain (otalgia). It is not rare that hearing 
disturbance in a patient later on found out to be NPC [1, 2, 8]. 
Nasopharyngeal symptoms might be mild nosebleed or nasal 
obstruction, therefore a thorough nasopharyngeal examination should be 
performed. If necessary, nasopharyngoscope should be performed due to 
common cases of creeping tumor, which is a presence of tumor without any 
symptom or visibility on the mucosal lining. A few cranial nerve 
disturbances may be found as a late symptom of NPC due to the adjacent 







location of tumor origin and cranial space through a couple of holes. 
Disturbance in the ear includes serous otitis media and conductive hearing 
loss. Neurological disturbance includes diplopia, loss of sensation in the 
cheek, decreased corneal reflex, and headache which involved cranial nerve 
number II, III, IV, V, and VI. Disruption of cranial nerve number IX, X, XI, 
and XII may cause dysphagia, soft palate hemiparesis, and tongue palsy. 
Due to the high location, disruption of cranial nerve number VII and VIII 
rarely occurs [4, 8]. 
Facial palsy is a weakness of facial muscles. A patient may not be able to 
move the facial muscle completely, therefore the patient’s face will show 
asymmetry. The causes of facial nerve palsy are congenital factor, infection, 
tumor, trauma, vascular problem, idiopathic, or due to certain disease. Among 
all cases of facial nerve palsy, 5% is reported due to tumor involvement with 
nasopharyngeal involvement only occurs in less than 1% [9]. 
The diagnosis of NPC requires history taking, physical examination, and 
other additional examination. Early detection in primary health care through a 
thorough history taking is required to increase the good prognosis in NPC 
patients. Nasoendoscopic examination plays a key role in early detection by 
detecting mucosal lining with suspicion of NPC lesion, as a guide to locate biopsy 
spot, and as a follow up for residual cases. Imaging modalities includes CT scan 
of nasopharynx in the level of frontal sinus to clavicula with coronal, axial, and 
sagittal section, with or without contrast [1, 2, 8]. 
A study found that EBV DNA analysis in plasma sample (pEBV) can 
be used as a screening tool for asymptomatic NPC. Marker of pEBC also 
has prognostic value as pEBV is used in selection of patient with high-risk 
NPC to receive adjuvant therapy. A definitive diagnosis is made based on 
histopathology finding with specimen taken through nasopharynx biopsy. 
WHO classify histopathology specimen into 4 types, including keratinized 
(WHO type I), non-keratinized and differentiated (WHO type II), and non-
keratinized and non-differentiated (WHO type III), and basaloid squamous 
cell carcinoma (WHO type IV) [4, 6, 7]. 
Table 1. TNM classificaton and saging of Nasopharyngeal Carcinoma of 
AJCC/UICC 8 [10] 
TNM Clasification Stadium AJCC 8 (2016) 
Tis 
 
Tumor is unidentified, but EBV status is 
positive on neck lymph node metastasis 
0 TisN0M0 
T1 Tumor is limited in nasopharynx, or extend to 
oropharynx and/or nasal cavity without 
parapharynx involvement 
I T1N0M0 
T2 Tumor with extension to parapharynx space, 
and/or involvement of adjacent soft tissue 
(medial pterygoid muscle, lateral pterygoid 





T3 Tumor infiltrate structures of cranial base, 
cervical vertebrae, pterygoid, and/or paranasal 
sinus 
T4 Tumor with intracranial extension, 
involvement of cranial nerves, hypopharynx, 
orbita, parotid gland, and/or infiltration to soft 
tissue extending to lateral border of lateral 
pterygoid muscle 






N1 Metastasis on neck lymph node unilaterally 
and/or metastasis on retropharynx lymph node 
uni/bilaterally with a size of < 6 cm on the 
widest dimension, superior to caudal border of 
cricoid cartilage. 
N2 Metastasis on neck lymph node bilaterally with 
a size of < 6 cm on the widest dimension, 
superior to caudal border of cricoid cartilage 
N3 Metastasis on neck lymph node uni/bilaterally 
with a size of > 6 cm on the widest dimension 
and/or extension to inferior to caudal border of 
cricoid cartilage 




M1 Distant metastasis 
IVB T1-T4,N0-N3,M1 
 
Modalities of therapy includes radiation, chemotherapy, combination of 
both, and supported by symptomatic therapy. 
 
Table 2. Modalities of therapy for NPC According to Its Stage 
Stage Modalities of Therapy 
Stage I Radiotherapy 
Stage II Chemoradiation 
Stage III Chemoradiation 
Stage IV with N <6 cm Chemoradiation 
Stage IV with N >6 cm Full-dose chemotherapy followed by chemoradiation  
 
Picture 1. Clinical views of the patient with facial asymmetry 
A woman aged 42 years old was referred from regional hospital with a 
complaint of nosebleed in the last 5 months that predominant in the right 
nasal cavity. The blood shed is in mild volume that it was able to be stopped 
by pinching the nose. Often, the blood flowed to the throat. There was no 
complaint of runny nose, post nasal drip, facial pain, nor nasal obstruction 
in the other nose, but there were complaints of blood-stain rhinorrhea, 
hyposmia, and intermittent headache.  
Mouth asymmetry had been complained since 4 months prior, 
accompanied by inability to close the right eyelid which cause a painful and 
watery eyes as well as sensation of thickness and stiffness in the right face. 
There was no currently happening ear discharge at the time of presentation, 
but there was history of ear discharge around 4 months prior. There was 
hearing loss that predominant in the right ear, accompanied by tinnitus 
without any pain nor vertigo. There was no complaint in the throat. There 
was no history of similar complaint in the family as well as any other 
comorbid diseases such as hypertension or diabetes. The patient underwent 
a nasopharynx biopsy in the regional hospital 3 months prior.  
The vital sign examinations were within normal value. On anterior 
rhinoscopy, a congested concha with hyperemic mucosal lining was found. 
On nasoendoscopic examination, a mass on the right nasopharynx with 
irregular surface and high susceptibility to bleed was found. Soft palate 
phenomenon was not found on the right nasal cavity. Otoscopy examination 
of right acoustic meatal was found normal with a moderate perforation on 
the tympanic membrane. There was no discharge nor granulation and 
retroauricular space showed no swelling nor hyperemic appearance. 
Oropharynx examination revealed normal findings and no enlargement of 
lymph node was found. 
Table 3. Clinical Facial Nerve Examination 
Examination Right Left 
Frowning - +++ 
Closing the eye lid - +++ 
Showing the teeth - +++ 
Whistling - +++ 
Taste in 2/3 anterior of the tongue - + 
Hyperacussis - - 
Tear secretion + + 
 
There was obvious disfiguring difference between two sides, lack of 
movement of the right forehead and eyebrows.  At rest asymmetry and 
tone of facial muscles were present. Patient was unable to voluntarily 
close eyes completely with effort and reduced movement on forehead was 
seen on motion. The tip of the nose is drawn to the unaffected side. She 
had paraesthesia in 2/3 anterior of the tongue. No associated pain over 







Graphic 1. Pure Tone Audiometry (PTA), Right: Moderate Severe Mix 
Hearing Loss (57.5 dB); Left: Mild Conductive Hearing Loss (33.75 dB) 
 
 







The patient had a hearing loss in both ear especially of the right ear. The 
result of Pure tone Audiometry showed a moderate severe mix hearing loss 
(57.5 dB) of the right ear and mild conductive hearing loss (33.75 db) of the 
left ear. 
 
Picture 2. CT scan of Nasopharynx in Coronal Section  
 
Additional examination was done with CT scan of nasopharynx in 
coronal section and a mass was found on the right side of nasopharynx with 
a shallow fossa of rossenmuller with any extent on parapharyngeal space. 
Bone survey and abdominal ultrasound showed no sign of metastatic sign. 
Histopatology finding from biopsy of nasopharynx shows tendency to Non-
Keratinizing Squamous Cell Carcinoma. 
Based on history taking, physical examination, and several additional 
examinations performed, the working diagnosis was Nasopharyngeal 
Carcinoma Stage IVA (T4 N0 M0) with facial nerve paresis (Hause-
Brackmann V). The intervention done for the patient was radiotherapy. 
 
1.1 Follow up 
The patient came to the ENT clinic for a control check-up after 
undergoing 35 cycles of radiotherapy. There was no complaint of nosebleed, 
runny nose, nasal obstruction, facial pain, nor headache. The intensity of 
tinnitus decreased but the hearing loss persist. There was no pain in the ear 
nor vertigo. Paresis of the face seemed to have a mild relief. Patient was 














Picture 3. Clinical views of the patient after undergoing radiotherapy 
 
Table 4. Clinical Facial Nerve Examination 
Examination Right Left 
Frowning + +++ 
Closing the eye lid + +++ 
Showing the teeth + +++ 
Whistling + +++ 
Taste in 2/3 anterior of the tongue + + 
Hyperacussis - - 
Tear secretion + + 
 
On clinical examination, paresis of the face seemed to have a mild relief. 
Lack of movement of the right forehead and eyebrows still appeared.  At 
rest normal symmetry and tone of facial muscles were present. Patient was 
able to voluntarily close eyes completely with effort. She had no change in 
taste sensation or paraesthesia, no dry eyes or tearing on salivation, no 
excessive facial sweating or sweating on salivation. 
A control CT scan examination of nasopharynx with coronal section 
found a thickness on mucosal lining of the right pharyngeal space with a 
shallow fossa of rossenmuller. The finding concluded that there was a relief 
compared to the initial CT scan finding before the patient underwent 
radiotherapy. Besides, a CT Scan of Mastoid with axial section was done 
with a finding of air cell mastoid opacification that predominant in the right 
ear, concludes a finding of right otomastoiditis. 
 
Picture 4. CT scan of Nasopharynx after Radiotherapy Session 
 
Based on history taking, physical examination, and several additional 
examinations performed, the working diagnosis after radiotherapy session 
was Nasopharyngeal Carcinoma Stage IVA (T4 N0 M0) with facial nerve 
paresis (Hause-Brackmann III). The proposed action for the patient was 500 
mg of oral mecobalamin tablet every 12 hours and a referral to medical 
rehabilitation department. 
2. DISCUSSION 
One fifth of NPC patients have cranial nerve involvement at the time of 
diagnosis. The nearby location of rossenmuller fossa to lacerum foramen 
and middle base of the cranium provide way for tumor to extent directly to 
the cranium and adjacent cranial nerve. Involvement of trigeminal nerve is 
the most common finding of all, followed by abducent nerve that causes 
facial pain, paresthesia, and diplopia [11]. A group of symptoms caused by 
disruption of anterior cranial nerves due to NPC metastasis is called 
Petrosphenoid Syndrome. However, NPC can also affect cranial nerve 
number IX, X, and XI in parapharyngeal space, causing palsy on the tongue, 
palate, pharynx, throat, sternocleidomastoid muscle, and trapezius muscle. 
This syndrome might cause trismus, aphonia due to vocal cord palsy, 
dysphagia, and nerve palsy of sympathetic cervical nerve (Horner 
Syndrome) [4, 8, 12]. 
Facial palsy is a weakness of facial muscle. The patient is unable to 
move its face muscle completely, causing asymmetrical face. Among all 
facial nerve palsy, 5% is reported to be caused by tumor, one of which is 
NPC. Facial palsy due to NPC does not happen very often, with incidence 
only compromise less than 1% of all cases. After arising from brainstem, the 
facial nerve enters the cerebellopontine angle (CPA), temporal bone 
(internal acoustic meatal, middle ear, and mastoid) and parotid gland before 
then branching to innervate the facial muscles. Tumor involvement along 
the pathway may cause facial palsy [9, 13]. 
Involvement of facial nerve in CPA is probably due to metastasis (via 
hematogenous, CSF, or leptomeningeal spread), whereas involvement in 
middle ear is probably due to direct invasion (through eustachian tube or 
direct invasion from parapharyngeal space) or through metastasis. Indirect 
invasion might due to tubal occlusion. The nearby location of eustachian 
tube and fossa of rossenmuller might cause a negative pressure inside the 
tympanic cavity leading to otitis media and if left untreated might cause 
mastoiditis in the long run. Involvement of facial nerve due to disruption of 
parotid gland might give a hint of lymphatic spread to the retropharynx 
group of lymph node [8, 14]. 
On this patient, a sign of intratemporal complication was found. Facial 
nerve paresis might be caused by indirect spread to middle ear through 
eustachian tube. Moreover, CT Scan of Mastoid with axial section revealed 
right otomastoiditis and moderate perforation on the right tympanic 
membrane that might be caused by indirect mechanism of spread.  
The ideal therapy on this patient is concurrent chemoradiation, 
chemotherapy and radiation done at the same time. Tumor response towards 
radiation generally increased on combination with chemotherapy 
medications such as Cisplatin, 5 FU, Hydroxyurea, and Mytomkin. The 







advantage of concurrent chemoradiation is that both work in synergy to 
prevent resistance, kill hypoxic subpopulation of cancerous cell, and inhibit 
DNA recovery on sublethal cancerous cell [15]. However, the patient 
refused to undergo chemotherapy, so the only therapy done in this case was 
radiotherapy. Chemoradiation have contributed to improvements in 
functional organ preservation. The study by Wang et al (2018) reported that 
compared with those threated with radiation therapy alone, chemoradiation 
could significantly improve patients prognosis in terms of overall survival, 
and progression free survival in nasopharyngeal carcinoma [16]. 
After undergoing 35 cycles of radiotherapy, a significant improvement 
was seen clinically on the patient. Before undergoing radiotherapy, patient 
was identified with Hause Brackmann grade V and after therapy it improved 
to grade III.  
3. CONCLUSION 
We reported a case of 42 years old female with stage IVA 
Nasopharyngeal Carcinoma (T4N0M0) with facial nerve paresis (Hause 
Brackman V) who underwent radiotherapy with 35 cylces with fair 
response. Facial palsy due to NPC does not happen very often, with 
incidence only compromise less than 1% of all cases. Therefore, it is 
important to understand the anatomy of nasopharynx structure and facial 
nerve pathway to provide an accurate clinical evaluation for the patient. 
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